Fosun pharmaceutical (600196) announced on the evening of June 22, the company's board of directors noted that the company's a-share price fluctuated sharply on June 22. The company has checked and verified that the company's current production and operation activities are normal; As of the announcement day, the company does not have significant matters affecting the stock price of the company, and there are no major issues that should be disclosed and not disclosed.
|
